Genmab — December 2015
-
Nu er det jo lidt svært at gennemskue handlen, efter Nasdaq forringede deres produkt og mørklagde handlen for os private - men mon ikke europæiske investorer bliver tiltrukket af aktiver som GEN pga forventning om EU lempelser og FED stramninger?
-
på et eller andet tidspunkt skal GS jo nok komme - mon ikke det bliver på den anden side af ASH
-
jep - rente, USD, EUR - meget peger i retning af GEN
-
i hvert fald, hvis man er europæisk investor
-
Indien er nok meget fornuftigt at kigge på.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind